Jade Biosciences Inc. (JBIO)
NASDAQ · Healthcare
Jade Biosciences Inc. EPS 2025–2025
Jade Biosciences Inc. annual/quarterly eps history and growth rate from 2025 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Jade Biosciences Inc. eps for the quarter ending March 31, 2026 was $0.57, a 51.86% decrease year-over-year.
- Jade Biosciences Inc. annual eps for 2025 was $3.19.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Jade Biosciences Inc. EPS — FAQ
Jade Biosciences Inc. (JBIO) eps over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Jade Biosciences Inc.'s eps?
Jade Biosciences Inc. (JBIO) reported eps of $-3.19 for fiscal 2025.
Where can I see JBIO's eps history?
The chart and table above show Jade Biosciences Inc.'s eps by year and by quarter, including the growth rate.